Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574119 · ClinicalTrials.gov registry record · Phase 4

Effect of Aldosterone on Energy Starvation in Heart Failure

A Phase 4 study, sponsored by Vanderbilt University.

Completed
Registry status
Phase 4
Development phase
16
Enrollment target

NCT00574119: Completed Phase 4 study, sponsored by Vanderbilt University.

NCT00574119 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 16 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574119, a Phase 4 study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Phase 4
Development phase
16 participants
Enrollment target

Study Summary

We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magnetic resonance imaging to study metabolism, anatomy, function, blood flow and efficiency, before and after 6 months' treatment with the drug spironolactone which blocks the deleterious effects of the hormone aldosterone on the myocardium (heart muscle).

Primary Outcome

WMI=\[left ventricular stroke work/decay rate of 11C-acetate\]

Interventions

  • DRUG spironolactone

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2007-12
Est. Completion 2012-07
Phase Phase 4
Vanderbilt University

430 total trials

What the finished NCT00574119 record still lists

NCT00574119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which spironolactone is the first listed.

NCT00574119 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00574119 about?

NCT00574119 is a clinical study titled "Effect of Aldosterone on Energy Starvation in Heart Failure". We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magneti...

What is the current status of trial NCT00574119?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2007-12. Estimated completion is 2012-07.

What interventions are being tested in trial NCT00574119?

The interventions under investigation include: spironolactone (DRUG).

Who is sponsoring clinical trial NCT00574119?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00574119's enrollment target sits among peer trials

16 1869th of 2000 higher than 121 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00574119, the US trial registry maintained by the National Library of Medicine. NCT00574119 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.